
EditCo Sponsored Industry Symposium
This symposium will feature thought leaders in molecular oncology, gene editing, and computational biology, highlighting how CRISPR technologies are transforming cancer research.
Session Overview:
-
Dr. Simon Lebaron, Centre de Biologie Intégrative, University of Toulouse
Unveiling SURF2’s Role in Nucleolar Stress and Its Potential as a Therapeutic TargetRelated Case Study:
-
Dr. Daniel Miller, Evariste
AI-Driven Identification and Validation of Novel Synthetic Lethal Gene Pairs -
Dr. Amalia Soenens, EditCo Bio
Leveraging an Advanced CRISPR Platform to Streamline Oncology Breakthroughs
Our team will be available to discuss custom cell line engineering, CRISPR screening services, and how EditCo can support your next oncology-focused study.
Featured Poster Presentation
Session: Cancer Cell Biology
Date: June 18, 2025
Time: 10:45 – 20:00
Stop by to learn how our HiBiT knock-in cell line service enables highly sensitive, real-time protein monitoring—ideal for functional genomics, targeted protein degradation, and other cancer research applications.
Fill out the form below to schedule a 1 on 1 meeting with us!